The biological activities of tigliane, lathyrane, ingenane, casbane, jatropholane and premyrsinane diterpenoids which contain the gem-dimethylcyclopropyl unit are described. Particular attention is given to their anti-viral, anti-microbial and cytotoxic activities. In the main text there are 132 references. The electronic supplementary information contains tables listing 424 of these diterpenoids, their occurrence and biological activity together with the references.
Introduction
The study of the biological substrate-target interactions of proteins with organic molecules of low molecular weight, including Natural Products (NPs), has led to the identica-tion of the role of these proteins in several important biological processes. This eld of research has attracted great interest in recent years because it facilitates the study of complex cellular mechanisms, many of which have led to the recognition and identication of important biological targets.
The Natural Products include those containing a gem-dimethylcyclopropane subunit, some of which are considered to be of great interest for the discovery of new NP-based drugs due to their wide range of biological activities and structural diversity. Some of these compounds are currently under study in preclinical or clinical trials or have already been approved for the treatment of certain diseases.
2
This three-membered carbocycle is found in various types of compounds, particularly terpenoids, and these have been isolated from a large variety of organisms like plants, some fungi and marine organisms such as so corals and insects.
Natural Products with a gem-dimethylcyclopropane unit are mainly terpenoids and this carbocycle forms part of their basic skeleton.
Tables listing the known natural products of these structural types, the species from which they were isolated, their biological activities and references are available in the Electronic Supplementary Information (ESI). † 2 Diterpenoids with a gemdimethylcyclopropyl unit A large number of diterpenes contain a gem-dimethylcyclopropane ring. These diterpenes have a wide variety of carbon skeleta, derived from the cation casbane. They include tiglianes, lathyranes, ingenanes, casbanes, premyrsinanes and jatropholanes. They are mostly present in species of the Euphorbiaceae. These plants are of great interest in the search for new drugs based on Natural Products because of the wide variety of pharmacological properties they possess and the great diversity of compounds with high structural variability that they produce.
1,3
These polycyclic diterpenes, occurring widely in the Euphorbiaceae, can be formed by intramolecular cyclization of casbane. 4 Despite the recent advances in the understanding of the biosynthesis of many types of natural products, the specic enzymes responsible for building this strained three membered ring have only been identied in a few cases and many mechanistic details remain unclear. A number of enzymes in the terpenoid synthase family that catalyze cyclopropane formation have also been biochemically and mechanistically characterized recently, especially those responsible for the production of the bicyclic plant monoterpenes such as carene or sabinene synthase. 5 However the reported data on the biosynthesis and enzymatic formation of the cyclopropane ring in diterpenes are sparse. At least one diterpene synthase, casbene synthase, has been shown to cyclize geranylgeranyl pyrophosphate (GGPP) into casbene, which seems to be the key biosynthetic precursor of the lathyrane skeleton, an intermediate to jatropholane, tigliane, or premyrsinane which retain the cyclopropane ring in their nal structures.
5-9
This enzyme seems to follow a mechanism where cleavage of the allylic pyrophosphate moiety of GGPP, by a divalent metal ion, leads to an allylic carbocation that through alkylation and deprotonation generates the cyclopropane moiety in the casbane skeleton.
6-9
The ring strain present in the gem-dimethylcyclopropane moiety looks to be responsible for the biological activities of these compounds, many of them are potent alkylation agents. However, few reports about the biological relevance of this subunit have been published. For more detailed information about the biosynthesis and biological activity of this interesting subunit, the reader is directed to a recent excellent review.
5
Tiglianes and ingenanes, together with daphnanes are referred to as phorboids and are known for being proinammatory agents and tumor promoters which behave as protein kinase C (PKC) activators. Proof of the pharmacological relevance of this group of compounds is the FDA's approval in January 2012 of 3-O-angeloylingenol (PEP-005, Picato®, Leo Pharma) for the treatment of actinic keratosis, a precancerous skin condition. (2)) are a subclass of PKC activators since, unlike other phorbol esters, these do not induce tumor formation. Prostratin (2) has been found in Euphorbia species. 23, 24 Recently, it has been shown that prostratin is a PKC activator that is potentially useful in the treatment of HIV as it affects viral reservoirs in CD4
+ T-cells with a latent infection. 25 DPP (3) induces HIV-1 gene expression in latently infected cells at concentrations 20-40 times lower than prostratin. 26 Considering that the only structural difference between prostratin (2) and DPP (3) is the nature of the ester group bonded to the C-13 carbon, it is easy to associate the activity of the 12-deoxyphorbol skeleton with other phorbol esters such as 13-O-benzoyl-12-deoxyphorbol (4) which have exhibited the same type of behaviour in other studies. (7) (8) (9) , tiglianes that carry a glycoside group on the C-20 carbon, have a mild inhibitory effect on the HIV-1 virus. Fischeroside C (9) had an EC 50 value of 0.02 mM and a therapeutic index of 17.50, while prostratin (2) and 13,20-O-diacetyl-12-deoxyphorbol (10) were signicantly more active. 2.1.5 Tumor promotion activity. PMA (11) is a known protein kinase C activator that promotes tumors. [52] [53] [54] The esters, 35-39 also display tumor-promoting activity. 47 Phorbol esters do not induce tumors on their own but rather promote their growth by continuous exposure to certain levels of these esters.
38
In contrast to this ability to activate tumor growth, many malignant cells have been observed entering apoptosis in response to PKC activation by phorbol esters. PKC activity displacement is attributed to its role in the activation of different metabolic pathways, its cellular localization, phosphorylation, interaction with other molecules and accessibility to various substrates.
55,56
2.1.6 Other activities. Prostratin (2) exhibited analgesic and sedative effects in preliminary pharmacological assays carried out with mice. 22 Fischeroside B (8) provided signicant protection against the oxidative stress caused by tert-butylhydroperoxide by inhibiting the generation of reactive oxygen species and increasing glutathione levels in HepG2 cells. 57 Trigowiin A (60) exhibited antiviral activity against the Chikungunya virus. On the other hand, the HIV/AIDS eld is gaining momentum with the goal of nding a functional cure for HIV infection by utilizing strategies that specically reactivate the latent viral reservoir in combination with the Highly Active Antiretroviral Therapy (HAART). The virus HIV can be destroyed by HAART when it is active.
63 Compounds 69 and 70 were able to reactivate HIV-1 latency. Results with 69 strongly suggest that it reactivates HIV-1 through a PKC-dependent pathway. 30 Compound 70 induced cell-cycle arrest and HIV-1-LTR promoter activation and could be a novel lead compound for the development of therapies against HIV-1 latency. 64 2.2.3 Cytotoxic activity. Latilagascene B (65) showed antitumour activity against gastric carcinoma cells. 65 The diterpenoid esters 71-80 exhibited important cytotoxic activity.
66,67
Euphorbia factors L 1 (81) , L 3 (82) and japodagrol (83) exhibited in vitro anticancer activity.
68,69
2.2.4 Modulation of multidrug resistance. P-Glycoprotein (P-gp) is a multidrug transporter which is overexpressed in cancer cell plasma membranes as an efflux pump conferring cellular resistance to anticancer chemotherapy. Latilagascene B (65) was found to be an effective P-gp inhibitor and it is an inhibitor of multidrug resistance by tumor cells. It proved highly efficient in inhibiting rhodamine 123 efflux of the human MDR1 gene from transfected mouse lymphoma cells when compared to the untreated cells or the positive control verapamil.
70,71 Euphorbia factor L 10 (84) also inhibited the transport activity of this protein, exhibiting a higher level of activity than that of the specic and potent P-gp inhibitor cyclosporin A. 72 
Other activities. Latilagascenes A-C (64-66) and jolkinol B (68) are antitumor promoters and diminished the IE antigen expression of cytomegalovirus (CMV).
60 Besides, latilagascenes C (66) and D (85) exhibited high antineoplastic activity. 63 Lathyrane 69 has recently been patented as a promoter of stem cell proliferation in mouse brain. 73 Lathyrane 79 was particularly active as a prostaglandin E 2 inhibitor 74 and lathyrane 86 is a potent active ingredient in rabbit basilar and carotid arteries at resting tension. 75 Finally, lathyranes 87-91 showed signicant vascular-relaxing activity. (1) is a PKC activator exhibiting topical antitumor activity against human cancer cell lines in mice and against actinic keratosis in humans. PEP-005 also appears to have antileukemic effects, inducing apoptosis in leukemia cell lines and primary acute myeloid leukemia blasts. 77 The related compound PEP-008 (92) is a novel PKCactivating drug that arrests growth with senescence characteristics in solid cell lines derived from a variety of tissue types. This compound may therefore have therapeutic potential in a subset of breast cancer, colon cancer and melanoma tumors.
78
Euphorbia factor L 5 (93) acts as a cocarcinogen on the back skin in mice.
79 Kansuiphorin A-D (94-97) and 98-102 were cytotoxic against various cancer cell lines. 34, 35, 80, 83 2.3.2 Effects on cell division. Results showed that esters 98 and 103-112 signicantly inhibited cell division (0.5 mg ml À1 of each compound led to a reduction in cell division above 75%). Amongst these, 110 and 111 signicantly prevented cell cleavage. It should be noted that inhibitory activity was weaker in compounds with an acyl residue at position 13. Besides, compound 113 was tested and showed some activity (10 mg ml
À1
of this compound led to a 60% reduction in cell division). 
83,91-94
brown plant hopper and two-spotted spider mite. 81 Ingenol-3,20-diesters 132-138 showed weak piscicidal activity. 2.3.6 Other activities. Kansuiphorin A (94) showed antiviral activity and it is suggested that this compound prevents viral pneumonia in mice.
102 DBDI (122) inhibits degranulation in rat basophilic leukemia cells and results suggest that DBDI may have therapeutic potential for allergic diseases 103 and nally, compound 141 exhibits antiangiogenic activity. Additionally, casbene 144 had an antimicrobial effect on planktonic forms and the biolm arising from some bacteria and yeasts. Malaria is one of the most common parasitic infections worldwide. Plasmodium falciparum, a protozoan parasite, is the most prevalent strain in Africa and also the most fatal.
117
Jatropholone A (157) and compound 158 showed antiplasmodial activity against Plasmodium falciparum. 
Euphoractine group †
Euphoractines are Natural Products that contain the rare 5-6-7-3 fused diterpene core obtained from a lathyrane skeleton by chemical cyclization. 126 The listed euphoractines showed no biological activities.
127-130

Other diterpenes †
Other compounds with a gem-dimethylcyclopropane in the structures have been isolated from many different sources. However, their structures do not belong to the above groups and were therefore placed together in this sub-group.
2.8.1 Antimicrobial activity. Riolozatrione (168) acts as an antibiotic against Staphylococcus aureus. 
Conclusions and future outlook
In summary, this comprehensive review covered the isolation of diterpenes containing this gem-dimethylcarbocycle and whose biological activities are enhanced. The gem-dimethylcyclopropane ring remains intact in the biogenetic route leading to a large variety of secondary metabolites in many organisms. In fact, in these natural products the dimethylcyclopropyl unit remains as opposed to an isopropyl unit. This suggests the vital importance of this subunit in nature. Biological research on these gemdimethylcyclopropane derivatives has lent credence to the use of some plants in traditional medicine. Furthermore, the secondary metabolism of these plants and of a group of microorganisms, fungi or so corals, revealed new activities for those compounds.
The study of the structure-activity relationships of these compounds has gained momentum in recent years, especially with the study of interactions with proteins kinase C and it is to be expected that this trend will continue in the years to come.
On the other hand, the massive genome sequencing projects of different types of organisms will lead to the discovery and identication of new cyclopropane-ring containing natural products and their biosynthetic gene clusters, which will help to unveil new terpene synthases and additional mechanisms for gem-dimethylcyclopropane ring formation.
We anticipate that this substantial number of diterpenoids containing the gem-dimethylcyclopropane ring could be used in the study of in vivo protein-NP interactions with the aim of designing new drugs. A deeper study of these biological interactions will reveal the role of this intriguing ring in the pathway of the modulation of diverse proteins kinase C and it will allow to modulate them. The occurrence of a wide range of diterpenoids with this feature or even derivatized products that have resulted in biological activities supports the biological potential of these structures. This is the main reason why they should deserve more attention. Therefore, these metabolites and those that will be isolated in the future as well as related compounds offer scope for development as potential therapeutic agents. 
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